Alpha-GPC Side Effects: Headaches, TMAO and What We Know About Safety

Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a choline compound found in "focus" pre-workouts and nootropic stacks, promoted for power output and mental sharpness. It is generally described as well tolerated, yet questions have emerged about its long-term cardiovascular safety. Our editorial team reviewed what is known about its side effects, from everyday nuisances to the more serious signals from recent research.

What alpha-GPC is and why it is used

Alpha-GPC is a naturally occurring choline compound released when phospholipids in cell membranes are broken down. As a supplement, it provides choline in a form that crosses into the brain relatively well. By weight, roughly 40% of alpha-GPC is choline.

Choline is needed to make acetylcholine, the neurotransmitter that carries signals from nerves to muscles and plays a role in memory and attention. It is also a building block of cell membranes and a source of methyl groups. In some European countries, choline alfoscerate is a prescription medicine for cognitive decline, studied in trials such as that by De Jesus Moreno Moreno in Alzheimer's disease.

In sport, small studies have tested alpha-GPC before exercise. Ziegenfuss and colleagues reported a greater growth hormone response and higher peak force in a bench press test after a single 600 mg dose, while Bellar and colleagues found modest improvements in isometric strength after six days of supplementation.

These studies are small, short and not always replicated. Alpha-GPC is therefore best regarded as an experimental ingredient with limited evidence of benefit, which makes the balance with potential side effects particularly important.

Short-term side effects

At amounts used in sports studies, alpha-GPC is usually well tolerated. Reported side effects are generally mild and resolve when the dose is reduced or the supplement is stopped.

• Headache — one of the most common complaints, sometimes attributed to excess cholinergic activity.
• Digestive upset — heartburn, nausea, loose stools.
• Insomnia or restlessness — especially when taken in the evening or combined with stimulants.
• Dizziness and low blood pressure — reported occasionally.
• Skin rash — rare.
• Fishy body odour — at higher choline intakes, via trimethylamine.

Some users report low mood or "brain fog" when taking high amounts of choline sources, which they interpret as an excess of acetylcholine. Controlled data on this are lacking, but it is a reasonable signal to reduce or stop.

Pre-workout products complicate matters. When a formula combines alpha-GPC with caffeine, synephrine and other stimulants, it is difficult to attribute headaches or insomnia to any single ingredient.

TMAO and cardiovascular questions

The most significant concern about alpha-GPC relates to trimethylamine N-oxide (TMAO). Gut bacteria convert choline and related compounds into trimethylamine, which the liver then oxidises to TMAO. In a landmark Nature paper, Wang and colleagues linked higher TMAO levels to atherosclerosis in mice and to cardiovascular risk in humans.

In 2021, Lee and colleagues published a large Korean cohort study in JAMA Network Open. People prescribed alpha-GPC had a higher risk of stroke over ten years than non-users, even after adjusting for many risk factors. Because alpha-GPC is a medicine in Korea, users were often older and had cognitive complaints, so confounding cannot be excluded.

These findings do not prove that alpha-GPC causes strokes in young, healthy athletes. However, they mean that long-term daily use cannot be assumed to be harmless, especially in people with existing cardiovascular risk factors.

Researchers are still debating how much dietary TMAO precursors matter compared with kidney function, genetics and gut microbiota. Until clearer data exist, a cautious approach is sensible.

Interactions and groups who should avoid it

Because alpha-GPC increases acetylcholine availability, it may interact with medicines acting on the cholinergic system. These include drugs for dementia (such as donepezil), some medicines for overactive bladder and certain treatments for glaucoma. Anyone taking such medicines should consult a doctor before use.

People with a history of stroke, heart disease, or significant cardiovascular risk factors should avoid alpha-GPC unless advised otherwise by a clinician, given the observational signals described above.

There is insufficient safety data in pregnancy and breastfeeding. While choline is an important nutrient in pregnancy, the recommended sources are food and suitable prenatal supplements, not high-dose nootropic products.

The regulatory status of alpha-GPC in food supplements is not uniform across Europe, and in some countries it is regulated as a medicine. It is not on the WADA Prohibited List, but athletes subject to testing should choose batch-tested products.

Minimising risk if you use it

If you decide to try alpha-GPC as a healthy adult, using it occasionally rather than daily, and at the amounts studied (around 300–600 mg before training), limits total exposure. The US upper limit for total choline intake from all sources is 3.5 g per day for adults, set mainly to avoid fishy body odour and low blood pressure.

Avoid stacking multiple choline sources, such as alpha-GPC, citicoline and choline bitartrate, without adding up the total amount. Take it earlier in the day if you experience restlessness or poor sleep.

Consider whether you need it at all. Eggs, meat, fish and soya are good dietary sources of choline, and most performance benefits attributed to alpha-GPC are small and uncertain compared with well-established options such as caffeine and creatine.

Stop taking it and seek medical advice if you develop persistent headaches, palpitations, dizziness or any neurological symptoms such as weakness or speech difficulty — the latter requires an immediate 999 call.

Conclusions of the editorial team

Alpha-GPC is usually well tolerated in the short term, with headache, digestive upset and insomnia among the most common side effects.

Concerns about TMAO and an observational link with stroke mean that long-term daily use deserves caution, particularly in people with cardiovascular risk factors.

The performance benefits are modest and uncertain, so for many athletes the risk–benefit balance does not clearly favour regular use.

For related reading, see our articles on choline in the diet, caffeine and focus supplements, and how to read a pre-workout label.

References

1. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
2. Lee G, Choi S, Chang J, et al. Association of L-α glycerylphosphorylcholine with subsequent stroke risk after 10 years. JAMA Netw Open. 2021;4(11):e2136008.
3. Ziegenfuss T, Landis J, Hofheins J. Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. J Int Soc Sports Nutr. 2008;5(Suppl 1):P15.
4. Bellar D, LeBlanc NR, Campbell B. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. J Int Soc Sports Nutr. 2015;12:42.
5. De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003;25(1):178–193.
6. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press; 1998.